Remove Doctors Remove FDA Remove Sales Remove Side effects
article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

SKIMMERS SUMMARY: Jefferies analysts found doctors have shown strong interest in prescribing Aduhelm for about 35% of early-stage Alzheimer’s patients with mild cognitive impairment after surveying 50 U.S. sales alone, which is above consensus estimates of around $7 billion to $8 billion, the team said. Natalie Shure, The New Republic.

FDA 218
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

The FDA needs to study what people do when they see a DTC ad. Today, people don’t see a DTC TV ad and run to their doctor to ask for an Rx. Some DTC budgets are only released when certain sales targets are hit. ” Patients want to understand how the drug works and the potential side effects before starting therapy.

Marketing 285
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is it too late for Biogen?

World of DTC Marketing

Biogen will partner with Roche on the development, and potential sale of a promising cancer drug the Swiss pharma is advancing for several types of lymphoma, announcing Tuesday it’s exercised an option to share rights to the treatment. But is it too late for Biogen to stage a comeback with their reputation damaged?

article thumbnail

DTC marketing is an oxymoron

World of DTC Marketing

Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s side effects and cost. A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists side effects like cancer.

Marketing 265
article thumbnail

PM360 2022 Trailblazer Awards Product Launch of the Year Winner GEMTESA

PM360

received FDA approval for once-daily GEMTESA—the first new oral OAB medication approved by the FDA since 2012. The treatment gap is evident: of those 30 million Americans with OAB, only 16 million have seen a doctor about the condition and only three million people are on treatment at any given time.

article thumbnail

7 Pharmaceutical Industry Trends for your 2021 Marketing Strategy

Silver Line CRM

In order to advance the effective delivery of healthcare for individuals, health information systems must work together within and across organizational boundaries. Internally, this means updating legacy systems and combining multiple data sources like ERP and marketing/sales systems needed to be effective. Insurance companies

article thumbnail

Getting approval will only be the first challenge facing lecanemab

pharmaphorum

GlobalData notes that the side effect could be a barrier for lecanemab use as it will require patient monitoring, but points out that the rates are a “significant improvement” on Aduhelm, which had an ARIA-E rate of 35% of patients taking the approved dose in clinical trials. In Clarity AD, the rate of ARIA-E was 12.5%

Doctors 52